ClinicalTrials.Veeva

Menu
U

University of Rochester Medical Center | Wilmot Cancer Institute

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Melphalan
Fludarabine
Busulfan
Cyclophosphamide
Thiotepa
Mosunetuzumab
LY3484356
Ribociclib
Lisinopril
Cisplatin

Parent organization

This site is a part of University of Rochester Medical Center

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 11 total trials

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors (PIKASSO-01)

The main purpose of this study is to learn more about the safety, side effects, and effectiveness of LOXO-783. LOXO-783 may be used to treat breast c...

Active, not recruiting
Breast Cancer
Drug: Anastrozole, Exemestane, or Letrozole
Drug: Paclitaxel

The reason for this study is to see if the study drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in part...

Active, not recruiting
Endometrial Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Everolimus

Older patients with diffuse large B- cell lymphoma (DLBCL) do not have the same rates of disease control as younger patients and are at risk for toxi...

Enrolling
Diffuse Large B-Cell Lymphoma (DLBCL)
Drug: Mosunetuzumab
Device: ClonoSEQ

Trial sponsors

University of Rochester logo
Lilly logo
City of Hope logo
D

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems